Francesco Rubino is Chair of Metabolic and Bariatric Surgery in the School of Cardiovascular and Metabolic Medicine and Sciences at King’s College London, UK, and specialises in laparoscopic bariatric, metabolic and upper digestive surgery. Prior to taking up his current position, he served as the Director of the Diabetes Surgery Centre and as Chief of Gastrointestinal Metabolic Surgery at the New York Presbyterian Hospital and the Weill Cornell Medical College in New York, USA.

He received his medical degree and completed his residency in general surgery at the Catholic University/Policlinico Gemelli in Rome, Italy, and completed fellowships in laparoscopic surgery at the European Institute of Telesurgery in Strasbourg, France, the Mount Sinai Medical Center, New York, and the Cleveland Clinic, Ohio.

His research has shown that the anti-diabetes effect of certain bariatric procedures, particularly gastric bypass surgery, results from mechanisms beyond weight loss. This evidence provided a scientific rationale for surgical treatment of type 2 diabetes, including that of less obese patients. His research and theories also point to a role of the gastrointestinal tract in the pathophysiology of diabetes and obesity.

Professor Rubino was one of the co-organisers of the landmark Diabetes Surgery Summit an influential series of consensus conferences where leading international authorities reached a consensus on the best candidates for the surgical treatment of type 2 diabetes.

Duality of interest: Professor Rubino has received research support / grants from Medtronic, Ethicon Endosurg. and Novo Nordisk and speaker’s honorarium / fees from Medtronic, Ethicon Endosurg. and Novo Nordisk. He has also received board member / advisor panel payments from GT Metabolic Solution together with consultancy fees from Medtronic, Ethicon Endosurg. and GI dynamics. Professor Rubino is the president of the Metabolic Health Institute.

Date: Summer 2023